Dr. MartensDOCMF 53 14-Day RSI is 64.50 as of Jun. 27, 2026. GuruFocus rates DOCMF with a GF Score™ of 53/100 and a GF Value™ of $0.97 (Fairly Valued). The stock has 3 warning signs investors should review. Among 1,166 Manufacturing - Apparel & Accessories companies, Dr. Martens ranks worse than 73.67% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-06-27), Dr. Martens's 14-Day RSI is 64.50.
The industry rank for Dr. Martens's 14-Day RSI or its related term are showing as below:
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Dr. Martens 14-Day RSI Related Terms
DOCMF vs NKE, DECK, ONON: 14-Day RSI Comparison
For the Footwear & Accessories subindustry, Dr. Martens's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr. Martens 14-Day RSI vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Dr. Martens's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Dr. Martens's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr. Martens (DOCMF) has a 14-Day RSI of 64.50 as of Jun. 27, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Dr. Martens and its competitors. According to the industry distribution chart, Dr. Martens ranks #859 out of 1166 companies in the Manufacturing - Apparel & Accessories industry, placing it in the top 73.7%.
Is Dr. Martens' 14-Day RSI too high?
Dr. Martens' current 14-Day RSI is 64.50. The Manufacturing - Apparel & Accessories industry median 14-Day RSI is 47.24. Dr. Martens' value of 64.50 is 36.6% above this industry median. Based on the distribution chart, Dr. Martens ranks #859 out of 1166 companies in the Manufacturing - Apparel & Accessories industry, which is below the industry midpoint. Overall, Dr. Martens has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dr. Martens' 14-Day RSI compare to NKE and DECK?
According to the Manufacturing - Apparel & Accessories industry distribution chart, Dr. Martens ranks #859 out of 1166 companies for 14-Day RSI. This places Dr. Martens in the lower half of its industry. The industry median 14-Day RSI is 47.24. Dr. Martens' value of 64.50 is 36.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Manufacturing - Apparel & Accessories company?
The median 14-Day RSI among Manufacturing - Apparel & Accessories companies is 47.24, based on 1,166 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr. Martens's current 14-Day RSI of 64.50 is 36.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Dr. Martens and its competitors. For the Manufacturing - Apparel & Accessories industry, the median 14-Day RSI is 47.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr. Martens's current 14-Day RSI is 64.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr. Martens stock overvalued right now?
Based on GuruFocus' analysis, Dr. Martens (DOCMF) is currently considered Fairly Valued. The stock's GF Value™ is $0.97, compared to a current price of $0.97 — trading right at its estimated fair value. The current 14-Day RSI is 64.50 and 36.6% above the Manufacturing - Apparel & Accessories industry median of 47.24. Dr. Martens' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Dr. Martens (DOCMF), the current 14-Day RSI is 64.50 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr. Martens (DOCMF) Overvalued in 2026?
Based on GuruFocus' analysis, Dr. Martens stock appears to be undervalued.
The current stock price of $0.97 is trading 0% below its estimated GF Value™ of $0.97.
GuruFocus considers Dr. Martens to be Fairly Valued.
Key valuation signals for DOCMF:
14-Day RSI: 64.50
GF Value™: $0.97 vs. price of $0.97 (0% below fair value)
Industry Position: 36.6% above the Manufacturing - Apparel & Accessories median (#859 of 1166)
No single metric tells the full story. See the DOCMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr. Martens PLC is engaged in the footwear business. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories. The company has sales through E-commerce, Retail, and Wholesale of Products. Geographically, it derives the majority of its revenue from EMEA and has a presence in the Americas and APAC.
53GF Score
Get the complete analysis for DOCMF
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DOCMF has been successfully added to your 